Clinical Trials Browser

Phase 2 × OTHER × Histocompatibility Testing × Clear all

NCT00319735 2016-04-28

Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas

Phase 2 Completed

41 enrolled 18 charts

Gastrointestinal

Esophageal Neoplasms